(Q36532115)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16831079%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

review article

1 reference

title

Chemotherapy resistance in osteosarcoma: current challenges and future directions (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16831079%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

1

Alexander J Chou

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16831079%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

14 August 2017

2

Richard Gorlick

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16831079%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

14 August 2017

language of work or name

1 reference

1 July 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16831079%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Anticancer Therapy

26 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16831079%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16831079%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16831079%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

page(s)

1075-1085

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16831079%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.7.1075

Common musculoskeletal tumors of childhood and adolescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.7.1075

Biology and therapeutic advances for pediatric osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.7.1075

Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: osteosarcoma and related tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.7.1075

Post-translational modification of p53 in tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.7.1075

The retinoblastoma tumour suppressor in development and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.7.1075

Stem-like cells in bone sarcomas: implications for tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.7.1075

CDKN2A gene deletions and loss of p16 expression occur in osteosarcomas that lack RB alterations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.7.1075

Reduced folate carrier protein expression in osteosarcoma: implications for the prediction of tumor chemosensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.7.1075

Her-2/neu expression in osteosarcoma increases risk of lung metastasis and can be associated with gene amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.7.1075

Pattern of disease recurrence and prognostic factors in patients with osteosarcoma treated with contemporary chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.7.1075

Treatment of osteosarcoma at first recurrence after contemporary therapy: the Memorial Sloan-Kettering Cancer Center experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.7.1075

Ifosfamide in Pediatric Solid Tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.7.1075

Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.7.1075

Long-term results of the co-operative German-Austrian-Swiss osteosarcoma study group's protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.7.1075

Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.7.1075

Phase II study of ecteinascidin 743 in heavily pretreated patients with recurrent osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.7.1075

Mechanisms of cancer drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.7.1075

Phase II study of 5-fluorouracil/leucovorin for pediatric patients with malignant solid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.7.1075

The role of methotrexate in osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.7.1075

Cisplatin: mode of cytotoxic action and molecular basis of resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.7.1075

Cellular pharmacology of cisplatin in relation to the expression of human copper transporter CTR1 in different pairs of cisplatin-sensitive and -resistant cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.7.1075

A family of drug transporters: the multidrug resistance-associated proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.7.1075

Mechanisms controlling sensitivity to platinum complexes: role of p53 and DNA mismatch repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.7.1075

Dickkopf 3 inhibits invasion and motility of Saos-2 osteosarcoma cells by modulating the Wnt-beta-catenin pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.7.1075

IGF-1 receptor contributes to the malignant phenotype in human and canine osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.7.1075

Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.7.1075

Anthracycline drug targeting: cytoplasmic versus nuclear--a fork in the road

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.7.1075

Osteosarcomas and other cancers of bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.7.1075

Value of P-glycoprotein and clinicopathologic factors as the basis for new treatment strategies in high-grade osteosarcoma of the extremities

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.7.1075

The association of P-glycoprotein with response to chemotherapy and clinical outcome in patients with osteosarcoma. A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.7.1075

Clinical significance of P-glycoprotein immunohistochemistry and doxorubicin binding assay in patients with osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.7.1075

The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.7.1075

Control of multidrug resistance gene mdr1 and cancer resistance to chemotherapy by the longevity gene sirt1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.7.1075

Intrinsic and acquired resistance to methotrexate in acute leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.7.1075

Anticancer Antifolates: Current Status and Future Directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.7.1075

Lack of functional retinoblastoma protein mediates increased resistance to antimetabolites in human sarcoma cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.7.1075

Analysis of dihydrofolate reductase and reduced folate carrier gene status in relation to methotrexate resistance in osteosarcoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.7.1075

Genomic imbalances associated with methotrexate resistance in human osteosarcoma cell lines detected by comparative genomic hybridization-based techniques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.7.1075

MRP subfamily transporters and resistance to anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.7.1075

21 January 2018

Novel antifolate drugs

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.7.1075

Phase II/III trial of etoposide and high-dose ifosfamide in newly diagnosed metastatic osteosarcoma: a pediatric oncology group trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.7.1075

Radiotherapy for local control of osteosarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.7.1075

4-Demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin (PNU-159548): a promising new candidate for chemotherapeutic treatment of osteosarcoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.7.1075

Efficacy and safety of liposomal anthracyclines in phase I/II clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.7.1075

The FKBP12-rapamycin-binding domain is required for FKBP12-rapamycin-associated protein kinase activity and G1 progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.7.1075

Rapamycin inhibits ezrin-mediated metastatic behavior in a murine model of osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.7.1075

Advances that are changing the diagnosis and treatment of malignant bone tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.7.1075

Antitumor activity of the insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 in musculoskeletal tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.7.1075

Treatment of metastatic osteosarcoma with the somatostatin analog OncoLar: significant reduction of insulin-like growth factor-1 serum levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.7.1075

Molecular Mechanisms of Bone Metastasis and Therapeutic Implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.7.1075

Role of endothelin-1 in osteoblastic bone metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.7.1075

Messenger RNA expression levels of CXCR4 correlate with metastatic behavior and outcome in patients with osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.7.1075

Evaluation of the role of RANK and OPG genes in Paget's disease of bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.7.1075

Importance of membrane- or matrix-associated forms of M-CSF and RANKL/ODF in osteoclastogenesis supported by SaOS-4/3 cells expressing recombinant PTH/PTHrP receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.7.1075

Human osteosarcoma-derived cell lines produce soluble factor(s) that induces differentiation of blood monocytes to osteoclast-like cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.7.1075

Investigation of the effect of pamidronate disodium on the in vitro viability of osteosarcoma cells from dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.7.1075

Alendronate regulates cell invasion and MMP-2 secretion in human osteosarcoma cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.7.1075

Zoledronic acid suppresses lung metastases and prolongs overall survival of osteosarcoma-bearing mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.7.1075

Treatment and outcome of recurrent osteosarcoma: experience at Rizzoli in 235 patients initially treated with neoadjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.7.1075

10.1586/14737140.6.7.1075

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16831079%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference